Egyptian Pharmaceutical Journal

REVIEW ARTICLE
Year
: 2018  |  Volume : 17  |  Issue : 3  |  Page : 129--140

Antiepileptic drugs: progress and development


Mona E Aboutabl 
 Medicinal and Pharmaceutical Chemistry (Department Pharmacology Group), Pharmaceutical and Drug Industries Research Division, National Research Centre, (ID: 60014618), 33 El Bohouth Street, Dokki, Giza, Egypt

Correspondence Address:
Dr. Mona E Aboutabl
Medicinal and Pharmaceutical Chemistry (Department Pharmacology Group), Pharmaceutical and Drug Industries Research Division, National Research Centre (ID: 60014618), 33 El Bohouth Street, Dokki, Giza 12622
Egypt

Epilepsy remains one of the most challenging diseases worldwide. According to the WHO, ∼50 million people around the world experience epilepsy with all its implications on the patient’s overall quality of life and social life as well as social stigma. The causes of epilepsy are mostly unknown. Epilepsy treatment is considered as a huge economic burden on the patient and health care systems. This review aimed to shed light on the different types of epilepsy, the different mechanisms of action of the most novel antiepileptic drugs in the market, as well as the current antiepileptic drugs under investigation and undergoing clinical trials.


How to cite this article:
Aboutabl ME. Antiepileptic drugs: progress and development.Egypt Pharmaceut J 2018;17:129-140


How to cite this URL:
Aboutabl ME. Antiepileptic drugs: progress and development. Egypt Pharmaceut J [serial online] 2018 [cited 2019 Mar 21 ];17:129-140
Available from: http://www.epj.eg.net/article.asp?issn=1687-4315;year=2018;volume=17;issue=3;spage=129;epage=140;aulast=Aboutabl;type=0